Metabolic tumour volume and response to therapy in diffuse large B-cell lymphoma
- PMID: 30933368
- DOI: 10.1002/hon.2612
Metabolic tumour volume and response to therapy in diffuse large B-cell lymphoma
References
REFERENCES
-
- Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048-3058.
-
- Sasanelli M, Meignan M, Haioun C, et al. Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2014;41(11):2017-2022.
-
- Chang CC, Cho SF, Chuang YW, et al. Prognostic significance of total metabolic tumour volume on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy. Oncotarget. 2017;8(59):99587-99600.
-
- Campiotti L, De Palma D, Guasti L, et al. Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience. Q J Nucl Med Mol Imaging. 2019. epub ahead of print
-
- Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275-282.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources